Related references
Note: Only part of the references are listed.Ambivalence and Stigma Beliefs About Medication Treatment Among Young Adults With Opioid Use Disorder: A Qualitative Exploration of Young Adults? Perspectives
Sarah M. Bagley et al.
JOURNAL OF ADOLESCENT HEALTH (2023)
Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment
O. Trent Hall et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)
Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder
Anna Beth Parlier-Ahmad et al.
JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2022)
I wanted something that was more flexible: A qualitative study of patient preferences on choosing buprenorphine over methadone in a large, safety-net hospital opioid treatment program
Laura Checkley et al.
SUBSTANCE ABUSE (2022)
Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder
Kathryn Hawk et al.
JAMA NETWORK OPEN (2022)
Disparities by Sex and Race and Ethnicity in Death Rates Due to Opioid Overdose Among Adults 55 Years or Older, 1999 to 2019
Maryann Mason et al.
JAMA NETWORK OPEN (2022)
Racial/ethnic disparities in the availability of hospital based opioid use disorder treatment
Ji Eun Chang et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)
The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy
Ali Cheetham et al.
SUBSTANCE ABUSE AND REHABILITATION (2022)
Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic
Joseph R. Friedman et al.
JAMA PSYCHIATRY (2022)
Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic
Thuy Nguyen et al.
JAMA NETWORK OPEN (2022)
?You have to take this medication, but then you get punished for taking it:? lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period
Davida M. Schiff et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)
Accessibility of substance use treatment: A qualitative study from the non-service users' perspective
Laura Caris et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)
Vital Signs: Drug Overdose Deaths, by Selected Sociodemographic and Social Determinants of Health Characteristics — 25 States and the District of Columbia, 2019–2020
Mbabazi Kariisa et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study
Allison R. David et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2022)
Smartphone Ownership, Smartphone Utilization, and Interest in Using Mental Health Apps to Address Substance Use Disorders: Literature Review and Cross-sectional Survey Study Across Two Sites
Michael Hsu et al.
JMIR FORMATIVE RESEARCH (2022)
A collaborative culturally-centered and community-driven faith-based opioid recovery initiative: the Imani Breakthrough project
Chyrell D. Bellamy et al.
Social Work in Mental Health (2021)
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review
Karen Alexander et al.
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2021)
Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use
Mara A. G. Hollander et al.
DRUG AND ALCOHOL DEPENDENCE (2021)
Growing racial/ethnic disparities in overdose mortality before and during the COVID-19 pandemic in California
Joseph Friedman et al.
PREVENTIVE MEDICINE (2021)
Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees
Lauren A. Hoffman et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2021)
Disparities in Opioid Overdose Death Trends by Race/Ethnicity, 2018-2019, From the HEALing Communities Study
Marc R. Larochelle et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2021)
Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review
Erin Fanning Madden et al.
SUBSTANCE USE & MISUSE (2021)
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island
Seth A. Clark et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2021)
Telemedicine and healthcare disparities: a cohort study in a large healthcare system in New York City during COVID-19
Rumi Chunara et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2021)
Socioeconomic risk factors for fatal opioid overdoses in the United States: Findings from the Mortality Disparities in American Communities Study (MDAC)
Sean F. Altekruse et al.
PLOS ONE (2020)
Anti-racism and substance use treatment: Addiction does not discriminate, but do we?
Sara Matsuzaka et al.
JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE (2020)
Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts
Davida M. Schiff et al.
JAMA NETWORK OPEN (2020)
Digital Phenotyping to Enhance Substance Use Treatment During the COVID-19 Pandemic
Michael Hsu et al.
JMIR MENTAL HEALTH (2020)
Disparities in outpatient visits for mental health and/or substance use disorders during the COVID surge and partial reopening in Massachusetts
Jie Yang et al.
GENERAL HOSPITAL PSYCHIATRY (2020)
They look at us like junkies: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City
Brandon Muncan et al.
HARM REDUCTION JOURNAL (2020)
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Jennifer Rozylo et al.
ADDICTION SCIENCE & CLINICAL PRACTICE (2020)
Buprenorphine Treatment Divide by Race/Ethnicity and Payment
Pooja A. Lagisetty et al.
JAMA PSYCHIATRY (2019)
Life Expectancy and Mortality Rates in the United States, 1959-2017
Steven H. Woolf et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
I didn't want to be on Suboxone at first... - Ambivalence in Perinatal Substance Use Treatment
Bayla Ostrach et al.
JOURNAL OF ADDICTION MEDICINE (2019)
Everything is not right anymore: Buprenorphine experiences in an era of illicit fentanyl
Sydney M. Silverstein et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2019)
At the Expense of a Life: Race, Class, and the Meaning of Buprenorphine in Pharmaceuticalized Care
Alexandrea E. Hatcher et al.
SUBSTANCE USE & MISUSE (2018)
Management of opioid use disorders: a national clinical practice guideline
Julie Bruneau et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2018)
Exploring opioid use disorder, its impact, and treatment among individuals experiencing homelessness as part of a family
Avik Chatterjee et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City
Helena Hansen et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Experiences of opioid-dependent women in their prenatal and postpartum care: Implications for social workers in health care
Heather Howard
SOCIAL WORK IN HEALTH CARE (2016)
Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study
Cheryl Teruya et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2014)
Blacks And Hispanics Are Less Likely Than Whites To Complete Addiction Treatment, Largely Due To Socioeconomic Factors
Brendan Saloner et al.
HEALTH AFFAIRS (2013)
Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal-Access System
Jan Gryczynski et al.
AMERICAN JOURNAL ON ADDICTIONS (2013)
Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile
Joseph Pergolizzi et al.
PAIN PRACTICE (2010)
Why don't out-of-treatment individuals enter methadone treatment programmes?
James A. Peterson et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2010)